Cumberland Pharmaceuticals Inc CPIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $7.54
- Day Range
- $7.00–7.58
- 52-Week Range
- $1.88–9.28
- Bid/Ask
- $7.00 / $8.81
- Shares Outstanding
- 14.98M
- Market Cap
- $107.58M
- Volume/Avg
- 86,353 / 79,921
Key Statistics
- Price/Earnings (Normalized)
- 55.33
- Price/Sales
- 4.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.07%
Company Profile
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 93
- Website
- https://www.cumberlandpharma.com
Valuation
|
Metric
|
CPIX
|
|---|---|
Price/Earnings (Normalized) | 55.33 |
Price/Book Value | 6.16 |
Price/Sales | 4.78 |
Price/Cash Flow | — |
Price/Earnings
CPIX
Financial Strength
|
Metric
|
CPIX
|
|---|---|
Quick Ratio | 0.49 |
Current Ratio | 0.96 |
Interest Coverage | −42.20 |
Quick Ratio
CPIX
Profitability
|
Metric
|
CPIX
|
|---|---|
Return on Assets (Normalized) | −9.95% |
Return on Equity (Normalized) | −29.02% |
Return on Invested Capital (Normalized) | −21.49% |
Return on Assets
CPIX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|&D^^L#j | LOCK|s>LB | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|C^^&x?S | LOCK|$p@y | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|$&twZR | LOCK|&% | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|qsW&Z&P | LOCK|yV? | $33B | |||
| Viatris Inc
VTRS
| LOCK|Ng?C#d | LOCK|Y^c | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^M% | LOCK|?Gv | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|z<DjR$ | LOCK|fY | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|p&$r@f | LOCK|F? | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|tDtB&@< | LOCK|@#&! | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|#%J>v@ | LOCK|nj | $2B |
United States